Back

Biophysical modeling of the SARS-CoV-2 viral cycle reveals ideal antiviral targets

Castle, B. T.; Dock, C.; Hemmat, M.; Kline, S.; Tignanelli, C.; Rajasingham, R.; Masopust, D.; Provenzano, P.; Langlois, R.; Schacker, T.; Haase, A.; Odde, D. J.

2020-06-16 systems biology
10.1101/2020.05.22.111237 bioRxiv
Show abstract

Effective therapies for COVID-19 are urgently needed. Presently there are more than 800 COVID-19 clinical trials globally, many with drug combinations, resulting in an empirical process with an enormous number of possible combinations. To identify the most promising potential therapies, we developed a biophysical model for the SARS-CoV-2 viral cycle and performed a sensitivity analysis for individual model parameters and all possible pairwise parameter changes (162 = 256 possibilities). We found that model-predicted virion production is fairly insensitive to changes in most viral entry, assembly, and release parameters, but highly sensitive to some viral transcription and translation parameters. Furthermore, we found a cooperative benefit to pairwise targeting of transcription and translation, predicting that combined targeting of these processes will be especially effective in inhibiting viral production.Competing Interest StatementThe authors have declared no competing interest.View Full Text

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.